SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart Inc., a privately held, clinical-stage company developing recombinant vaccines that are administered by tablet rather than by injection, today announced that Wouter Latour, MD, chief executive officer, will provide an overview of the company at the JMP Securities Life Sciences Private Company Conference on Friday, October 17, 2014, at 8:40 a.m. EDT. The event will be held at Le Parker Meridian Hotel in New York. Dr. Latour will be available to participate in one-on-one meetings with investors who are registered to attend the conference. Investors can contact their JMP sales representative to schedule a meeting.
Help employers find you! Check out all the jobs and post your resume.
